ALGS
Aligos Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.84
−0.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 16.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.95x
- Price / sales
- 0.96x
- Price / cash flow
- -0.32x
Enterprise value
- Enterprise value
- $3.3M
- EV / sales
- 0.11x
- EV / EBITDA
- -0.05x
- EV / EBIT
- -0.04x
- Market cap
- $30.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026